Predicting who benefits from mitral valve percutaneous repair: It's not just the valve
- PMID: 32935948
- DOI: 10.1002/ccd.29212
Predicting who benefits from mitral valve percutaneous repair: It's not just the valve
Comment on
-
Predictors of left ventricular reverse remodeling after percutaneous therapy for mitral regurgitation with the MitraClip system.Catheter Cardiovasc Interv. 2020 Sep 1;96(3):687-697. doi: 10.1002/ccd.28779. Epub 2020 Feb 27. Catheter Cardiovasc Interv. 2020. PMID: 32104977
References
REFERENCES
-
- N Nita, D Scharnbeck, L-M Schneider. Predictors of left ventricular reverse remodeling after percutaneous therapy for mitral regurgitation with the MitraClip system. Catheter Cardiovasc Interv. 2020;96:687-697.
-
- Hahn R, Asch FM, Weissman NJ, et al. Gregg stone impact of tricuspid regurgitation on outcomes after mitraclip treatment of secondary mitral regurgitation: Results from the coapt trial. J Am Coll Cardiol. 2020;75(11 suppl):1. https://doi.org/10.1016/S0735-1097(20)31726-5.
-
- Velu JF, Hirsch A, Boekholdt SM, et al. Myocardial fibrosis predicts adverse outcome after MitraClip implantation. Catheter Cardiovasc Interv. 2019;93(6):1146-5. https://doi.org/10.1002/ccd.27993.
-
- Liu C-Y, Liu Y-C, Wu C, et al. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2013;62(14):1280-1287.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical